Factors Predicting Hostility in Outpatients With Schizophrenia 36-Month Results From the SOHO Study

被引:9
|
作者
Ochoa, Susana [1 ]
Suarez, David [1 ,2 ]
Novick, Diego [3 ]
Arranz, Belen [1 ]
Roca, Mercedes [1 ]
Bano, Vicente [1 ]
Maria Haro, Josep [1 ,4 ]
机构
[1] CIBERSAM, Barcelona 08830, Spain
[2] CIBERSAM, Fundacio St Joan de Deu, Barcelona 08830, Spain
[3] Eli Lilly & Co, Hlth Outcomes Res, Windlesham, Surrey, England
[4] Univ Barcelona, Fac Med, Barcelona 7, Spain
关键词
Schizophrenia; hostility; psychopathology; medication compliance; extrapyramidal effects; VIOLENT BEHAVIOR; OVERT AGGRESSION; INPATIENTS; CLOZAPINE; SYMPTOMS; RISPERIDONE; OLANZAPINE; DISORDER;
D O I
10.1097/NMD.0b013e31829480b0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
This analysis explored the prevalence, incidence, and predictors of hostility in the European Schizophrenia Outpatient Health Outcomes (EU-SOHO) study. Data were collected at baseline and up to 36 months on the presence of hostility, clinical course and severity, medication compliance, side effects, substance/alcohol abuse, and being a crime survivor. Regression models were fitted to test the association between predictors and the presence of hostility. Hostility prevalence in the 6 months before baseline was 27.9%, and the incidence at 3 years was 14.0%. Variables related to hostility during follow-up were age, male sex, alcohol/substance abuse, tardive dyskinesia, extrapyramidal symptoms, cognitive impairment, noncompliance, and hospitalization. Being a crime survivor, being married, not living independently, and not being in paid employment were associated with hostility at baseline. Clinical and social variables are related to hostility in schizophrenia. Extrapyramidal symptoms and tardive dyskinesia, alcohol/substance abuse, cognitive impairment, medication noncompliance, and hospitalizations are predictors of future hostility.
引用
收藏
页码:464 / 470
页数:7
相关论文
共 50 条
  • [21] Clinical course, social functioning, quality of life & medication tolerability in previously untreated patients with schizophrenia: 36-month results from the European schizophrenia outpatient health outcomes (SOHO) study
    Novick, D.
    Suarez, D.
    Brown, J.
    Gasquet, I.
    Haro, J. M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S387 - S388
  • [22] The European Schizophrenia Outpatient Health Outcomes Study: Effectiveness results of the French cohort of schizophrenic outpatients over a 36-month follow-up
    Gasquet, I.
    Chartier, F.
    Tcherny-Lessenot, S.
    Lepine, J. -P
    REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE, 2009, 57 (01): : 25 - 32
  • [23] 36-month cost-utility analysis of antipsychotic treatments in patients with schizophrenia in the pan-European soho (schizophrenia outpatient health outcomes) study
    Windmeijer, F.
    Brown, J.
    Novick, D.
    Hong, J.
    Knapp, M.
    Kontodimas, S.
    Ratcliffe, M.
    VALUE IN HEALTH, 2007, 10 (03) : A78 - A79
  • [24] Clinical consequences of switching from olanzapine to risperidone and viceversa in outpatients with schizophrenia: 36-months results from the Worldwide Schizophrenia Outpatients Health Outcomes (W-SOHO) study
    Novick, D.
    Hong, J.
    Brugnoli, R.
    Karagianis, J.
    Dossenbach, M.
    Haro, J. M.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 230 - 230
  • [25] Use of concomitant medication with antipsychotic treatment in outpatients with schizophrenia: Results from the European Schizophrenia Outpatients Health Outcomes (SOHO) study
    Novick, D
    Bousono, M
    Suarez, D
    Olivares, JM
    Montejo, AL
    Haro, JM
    Edgell, ET
    Ratcliffe, M
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2005, 29 (06): : 970 - 980
  • [26] Adaptation of the 36-month Ages and Stages Questionnaire in Taiwan: Results from a preliminary study
    Tsai, Huei-Ling Agnes
    McClelland, Megan M.
    Pratt, Clara
    Squires, Jane
    JOURNAL OF EARLY INTERVENTION, 2006, 28 (03) : 213 - 225
  • [27] Clinical status course and quality of life: 24-month results from the European schizophrenia outpatients health outcomes (SOHO) study
    Haro, JM
    Novick, D
    Belger, M
    Ratcliffe, M
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S496 - S496
  • [28] Long-term patterns of antipsychotic treatment of outpatients with schizophrenia: 24-Month results from the intercontinental schizophrenia outpatient health outcomes (IC-SOHO) study
    Bitter, I.
    Treuer, T.
    Dyachkova, Y.
    West, T.
    Martenyi, F.
    McBride, M.
    Ungvari, G.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S150 - S150
  • [29] BLADE IMPLANT CLINICAL-TRIAL - 36-MONTH RESULTS
    SCHNITMAN, P
    RUBENSTEIN, J
    JEFFCOAT, M
    BERTOLAMI, C
    SHULMAN, L
    KOCH, G
    JOURNAL OF DENTAL RESEARCH, 1987, 66 : 113 - 113
  • [30] Remission in the outpatient care of schizophrenia: 3-Year results from the Schizophrenia Outpatients Health Outcomes (SOHO) Study in France
    Gasquet, Isabelle
    Haro, Josep Maria
    Tcherny-Lessenot, Stephanie
    Chartier, Florence
    Lepine, Jean-Pierre
    EUROPEAN PSYCHIATRY, 2008, 23 (07) : 491 - 496